Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation
Main Authors: | , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
NIHR Journals Library
2006-03-01
|
Series: | Health Technology Assessment |
Online Access: | https://doi.org/10.3310/hta10090 |